Cellid corporate office is located in Seoul, Seoul-t'ukpyolsi, South Korea and has 11-50 employees.
cellid
cellid co ltd
CELLID recently finished the administration of subjects in Part C (Phase I) trial of its AdCLD-CoV19-1 COVID-19 vaccine, and shall submit IND for the next stage of clinical trials to the Ministry of Food and Drug Safety, Republic of Korea during Oct. 2021 and has plans to submit interim report of Global clinical trials & EUL on 1 st & 2 nd quarter... Read More